Ihr Ausdruck wurde in der folgenden Navigationsebene erstellt:
Publikationen von Mitarbeitern des GZ Tübingen 2011
Bigalke B, Schreitmüller B, Sopova K, Paul A, Stransky E, Gawaz M, Stellos K, Laske C. Adipocytokines and CD34 progenitor cells in Alzheimer's disease.PLoS One. 2011;6(5):e20286. Epub 2011 May 25.
Berg D, Seppi K, Behnke S, Liepelt I, Schweitzer K, Stockner H, Wollenweber F, Gaenslen A, Mahlknecht P, Spiegel J, Godau J, Huber H, Srulijes K, Kiechl S, Bentele M, Gasperi A, Schubert T, Hiry T, Probst M, Schneider V, Klenk J, Sawires M, Willeit J, Maetzler W, Fassbender K, Gasser T, Poewe W. Enlarged substantia nigra hyperechogenicity and risk for Parkinson disease: a 37-month 3-center study of 1847 older persons. Arch Neurol. 2011 Jul;68(7):932-7.
Brockmann K, Gröger A, Di Santo A, Liepelt I, Schulte C, Klose U, Maetzler W, Hauser AK, Hilker R, Gomez-Mancilla B, Berg D, Gasser T. Clinical and brain imaging characteristics in leucine-rich repeat kinase 2-associated PD and asymptomatic mutation carriers.Mov Disord. 2011 Nov;26(13):2335-42. doi: 10.1002/mds.23991. Epub 2011 Oct 11.
Frasch K, Weiser P, Becker T, Längle G, Steinert T, Niederreiner C, Pfiffner C, Jäger S, Bayer W, Eschweiler GW, Kilian R. Psychotropic Drug Treatment, Clinical Characteristics and Cognitive Processing Speed in Patients with Schizophrenia: Results from the ELAN Study. Pharmacopsychiatry. 2011 Dec 15. [Epub ahead of print]
Gerlach M, Maetzler W, Broich K, Hampel H, Rems L, Reum T, Riederer P, Stöffler A, Streffer J, Berg D. Biomarker candidates of neurodegeneration in Parkinson's disease for the evaluation of disease-modifying therapeutics.J Neural Transm. 2011 Jul 14. [Epub ahead of print]
Godau J, Knauel K, Weber K, Brockmann K, Maetzler W, Binder G, Berg D. Serum insulinlike growth factor 1 as possible marker for risk and early diagnosis of Parkinson disease. Arch Neurol. 2011 Jul;68(7):925-31.
Güler E, Leyhe T. A late form of neurosyphilis manifesting with psychotic symptoms in old age and good response to ceftriaxone therapy.Int Psychogeriatr. 2011 May;23(4):666-9. Epub 2010 Sep 15.
Hampel H, Prvulovic D, Teipel S, Jessen F, Luckhaus C, Frölich L, Riepe MW, Dodel R,
Leyhe T, Bertram L, Hoffmann W, Faltraco F; for the German Task Force on Alzheimer's Disease (GTF-AD). The future of Alzheimer's disease: The next 10 years.Prog Neurobiol. 2011 Dec;95(4):718-728. Epub 2011 Nov 22.
Hobert MA, Niebler R, Meyer SI, Brockmann K, Becker C, Huber H, Gaenslen A, Godau J, Eschweiler GW, Berg D, Maetzler W. Poor Trail Making Test Performance Is Directly Associated with Altered Dual Task Prioritization in the Elderly - Baseline Results from the TREND Study. PLoS One. 2011;6(11):e27831. Epub 2011 Nov 16.
Höglinger GU, Melhem NM, Dickson DW, Sleiman PM, Wang LS, Klei L, Rademakers R, de Silva R, Litvan I, Riley DE, van Swieten JC, Heutink P, Wszolek ZK, Uitti RJ, Vandrovcova J, Hurtig HI, Gross RG, Maetzler W, Goldwurm S, Tolosa E, Borroni B,Pastor P; PSP Genetics Study Group, Cantwell LB, Han MR, Dillman A, van der Brug MP, Gibbs JR, Cookson MR, Hernandez DG, Singleton AB, Farrer MJ, Yu CE, Golbe LI, Revesz T, Hardy J, Lees AJ, Devlin B, Hakonarson H, Müller U, Schellenberg GD. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet. 2011 Jun 19;43(7):699-705. doi: 10.1038/ng.859.
Klenk J, Becker C, Lieken F, Nicolai S, Maetzler W, Alt W, Zijlstra W, Hausdorff JM, van Lummel RC, Chiari L, Lindemann U. Comparison of acceleration signals of simulated and real-world backward falls. Med Eng Phys. 2011 Apr;33(3):368-73. Epub 2010 Nov 30.
Laske C.Blood-based biomarkers in Alzheimer disease.Arch Neurol. 2011 May;68(5):685-6; author reply 686. No abstract available.
Laske C.Blood-based biomarkers in Alzheimer disease.Arch Neurol. 2011 May;68(5):685-6; author reply 686. No abstract available.
Laske C, Fallgatter AJ, Stransky E, Hagen K, Berg D, Maetzler W. Decreased α-synuclein serum levels in patients with Lewy body dementia compared to Alzheimer's disease patients and control subjects.Dement Geriatr Cogn Disord. 2011;31(6):413-6. Epub 2011 Jul 13.
Laske C, Sopova K, Hoffmann N, Stransky E, Hagen K, Fallgatter AJ, Stellos K,Leyhe T.
Stem cell factor plasma levels are decreased in Alzheimer's disease patients with fast cognitive decline after one-year follow-up period: the Pythia-study.J Alzheimers Dis. 2011;26(1):39-45.
Laske C, Stellos K, Hoffmann N, Stransky E, Straten G, Eschweiler GW, Leyhe T.Higher BDNF serum levels predict slower cognitive decline in Alzheimer's disease patients.Int J Neuropsychopharmacol. 2011 Apr;14(3):399-404. Epub 2010 Sep 22.
Laske C, Leyhe T, Stransky E, Hoffmann N, Fallgatter AJ, Dietzsch J.Identification of a blood-based biomarker panel for classification of Alzheimer's disease.Int J Neuropsychopharmacol. 2011 Oct;14(9):1147-55. Epub 2011 Apr 5.
Leyhe T, Saur R, Eschweiler GW, Milian M. Impairment in proverb interpretation as an executive function deficit in patients with amnestic mild cognitive impairment and early Alzheimer's disease.Dement Geriatr Cogn Dis Extra. 2011 Jan;1(1):51-61. Epub 2011 Jan 22.
Liepelt-Scarfone I, Graeber S, Feseker A, Baysal G, Godau J, Gaenslen A, Maetzler W, Berg D. Influence of different cut-off values on the diagnosis of mild cognitive impairment in Parkinson's disease. Parkinsons Dis. 2011;2011:540843. Epub 2011 May 23.
Ludescher B, Machann J, Eschweiler GW, Thamer C, Maenz C, Hipp A, Claussen CD, Schick F. Active depression is associated with regional adiposity in the upper abdomen and the neck. Int J Psychiatry Med. 2011;41(3):271-80.
Maetzler W, Berg D, Synofzik M, Brockmann K, Godau J, Melms A, Gasser T, Hörnig S, Langkamp M. Autoantibodies against amyloid and glial-derived antigens are increased in serum and cerebrospinal fluid of Lewy body-associated dementias. J Alzheimers Dis. 2011;26(1):171-9.
Maetzler W, Stapf AK, Schulte C, Hauser AK, Lerche S, Wurster I, Schleicher E, Melms A, Berg D. Serum and cerebrospinal fluid uric acid levels in lewy body disorders: associations with disease occurrence and amyloid-β pathway.J Alzheimers Dis. 2011 Jan 1;27(1):119-26. doi: 10.3233/JAD-2011-110587.
Milian M, Leiherr AM, Straten G, Müller S, Leyhe T, Eschweiler GW. The Mini-Cog versus the Mini-Mental State Examination and the Clock Drawing Test in daily clinical practice: screening value in a German Memory Clinic. Int Psychogeriatr. 2011 Dec 15:1-9.
Müssig K, Besemer B, Saur R, Klingberg S, Häring HU, Gallwitz B, Leyhe T.Deteriorated executive functions in patients with successful surgery for pituitary adenomas compared with other chronically ill patients. J Int Neuropsychol Soc. 2011 Mar;17(2):369-75. Epub 2010 Dec 21.
Schmid SP, Schleicher ED, Cegan A, Deuschle C, Baur S, Hauser AK, Synofzik M, Srulijes K, Brockmann K, Berg D, Maetzler W. Cerebrospinal fluid fatty acids in glucocerebrosidase-associated Parkinson's disease. Mov Disord. 2011 Oct 21. doi: 10.1002/mds.23984. [Epub ahead of print]
Srulijes K, Mallien G, Bauer S, Dietzel E, Gröger A, Ebersbach G, Berg D, Maetzler W.In vivo comparison of Richardson's syndrome and progressive supranuclear palsy-parkinsonism. J Neural Transm. 2011 Aug;118(8):1191-7. Epub 2011 Jan 5.
Straten G, Saur R, Laske C, Gasser T, Annas P, Basun H, Leyhe T.Influence of Lithium Treatment on GDNF Serum and CSF Concentrations in Patients with Early Alzheimer's Disease.Curr Alzheimer Res. 2011 Aug 30. [Epub ahead of print]
Voigt-Radloff S, Graff M, Leonhart R, Schornstein K, Jessen F, Bohlken J, Metz B, Fellgiebel A, Dodel R, Eschweiler G, Vernooij-Dassen M, Olde Rikkert M, Hüll M. A multicentre RCT on community occupational therapy in Alzheimer's disease: 10 sessions are not better than one consultation.BMJ Open. 2011 Jan 1;1(1):e000096. Epub 2011 Aug 9.
